“Now there is a real chance to become a unicorn”: Slovenia’s GenePlanet secures strategic investment from Lauxera
GenePlanet, a Ljubljana-based genomics and laboratory platform delivering advanced genetic testing and next-generation sequencing (NGS) services worldwide, has secured a strategic investment from Lauxera Capital Partners, a specialist HealthTech investor. With this investment, the company’s existing investor BlackPeak Capital has partially exited its investment. It, however, retains a meaningful…
We haven't written up this one. EU-Startups has the full story — the link below goes straight to it.
